Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

828794

	registered interest
	date	23/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Kidney Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State, if he will take steps to ensure that people with diabetes are offered urine and blood tests to check for chronic kidney disease.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	124426
	answer	answer is ministerial correction date of answer 31/01/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) has published guidance on ‘Chronic kidney disease in adults’ which sets out best practice for clinicians on the diagnosis, treatment, care, and support of patients with chronic kidney disease (CKD). The guidance also includes recommendations for those at risk of developing CKD, including people with diabetes. NHS England expects commissioners to take account of NICE guidelines when delivering services.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 31/01/2018 12:34:13 answering member 4067 label Biography information for Steve Brine
	tabling member	4127 label Biography information for Julie Elliott

830542

	registered interest
	date	25/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Liothyronine
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether he plans to reduce the cost of liothyronine by procuring the drug from foreign suppliers; and if he will make a statement.
	tabling member constituency	Twickenham
	tabling member printed	Sir Vince Cable
	uin	125070
	answer	answer is ministerial correction date of answer 30/01/2018 answer text <p>The costs of branded medicines are controlled by the Pharmaceutical Price Regulation Scheme and the statutory scheme for branded medicines. Liothyronine is an unbranded generic medicine. For unbranded generic medicines, the Department encourages competition between suppliers to keep prices down. In primary care, community pharmacies are incentivised to source products at the lowest possible cost and in secondary care, competitive tenders ensure value-for-money to the National Health Service.</p><p> </p><p>Liothyronine is currently the subject of an investigation by the Competition and Markets Authority, which has provisionally found that the single supplier of the product abused its dominant position to overcharge the NHS by millions for liothyronine tablets. A provisional decision does not necessarily lead to an infringement decision. Where companies have breached competition law, the Department will seek damages and invest that money back into the NHS.</p><p> </p><p>Medicines legislation requires that only medicines licensed for use in the United Kingdom can be marketed in the UK.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 125067 question first answered 30/01/2018 17:14:17 answering member 4067 label Biography information for Steve Brine
	tabling member	207 label Biography information for Sir Vince Cable

830539

	registered interest
	date	25/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Liothyronine
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what estimate he has made of the money accrued to the public purse in relation to liothyronine under the (a) the voluntary Pharmaceutical Price Regulation Scheme and (b) the statutory scheme; and when those payments were made.
	tabling member constituency	Twickenham
	tabling member printed	Sir Vince Cable
	uin	125067
	answer	answer is ministerial correction date of answer 30/01/2018 answer text <p>The costs of branded medicines are controlled by the Pharmaceutical Price Regulation Scheme and the statutory scheme for branded medicines. Liothyronine is an unbranded generic medicine. For unbranded generic medicines, the Department encourages competition between suppliers to keep prices down. In primary care, community pharmacies are incentivised to source products at the lowest possible cost and in secondary care, competitive tenders ensure value-for-money to the National Health Service.</p><p> </p><p>Liothyronine is currently the subject of an investigation by the Competition and Markets Authority, which has provisionally found that the single supplier of the product abused its dominant position to overcharge the NHS by millions for liothyronine tablets. A provisional decision does not necessarily lead to an infringement decision. Where companies have breached competition law, the Department will seek damages and invest that money back into the NHS.</p><p> </p><p>Medicines legislation requires that only medicines licensed for use in the United Kingdom can be marketed in the UK.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 125070 question first answered 30/01/2018 17:14:17 answering member 4067 label Biography information for Steve Brine
	tabling member	207 label Biography information for Sir Vince Cable

830540

	registered interest
	date	25/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Liothyronine
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the effect on the level of caseloads of consultant endocrinologists as a result of changes to the prescription of liothyronine.
	tabling member constituency	Twickenham
	tabling member printed	Sir Vince Cable
	uin	125068
	answer	answer is ministerial correction date of answer 30/01/2018 answer text <p>The Department has made no assessment. It is for local clinical commissioning groups in conjunction with local providers to make decisions on implementing NHS England’s guidance on liothyronine and, as part of their decision making, to determine the resources available to implement any change.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 30/01/2018 17:10:32 answering member 4067 label Biography information for Steve Brine
	tabling member	207 label Biography information for Sir Vince Cable

819110

	registered interest
	date	09/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Energy Drinks: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health what assessment he makes of the health effects of energy drink products on children aged 16 and under.
	tabling member constituency	West Lancashire
	tabling member printed	Rosie Cooper
	uin	121787
	answer	answer is ministerial correction date of answer 15/01/2018 answer text <p>Energy drinks can be high in caffeine and sugar. Based on the current evidence on the safety of caffeine, the Food Standard Agency advises that children, or other people sensitive to caffeine, should consume caffeine only in moderation.</p><p> </p><p>In its review of the evidence on “Carbohydrates and Health” (2015), the Scientific Advisory Committee on Nutrition (SACN) concluded that the consumption of sugar-sweetened beverages, as compared with non-calorically sweetened beverages, results in greater weight gain and increases in body mass index. Consuming too many sugary drinks can also cause tooth decay. In light of these findings, SACN recommended that the consumption of sugar-sweetened beverages (for example, sugary fizzy drinks, soft drinks and squash) should be minimised by both children and adults.</p><p> </p><p>Key measures in our world-leading childhood obesity plan, launched in August 2016, include the soft drinks industry levy and sugar reduction and wider reformulation programme, which will encourage the food and drink industry to reduce the amount of sugar in products popular with children, including energy drinks.</p><p> </p><p>The Government will continue to monitor the situation and any new emerging scientific evidence on the consumption of energy drinks.</p><p> </p><p>“Carbohydrates and Health” is available at:</p><p> </p><p><a href="http://www.gov.uk/government/publications/sacn-carbohydrates-and-health-report" target="_blank">www.gov.uk/government/publications/sacn-carbohydrates-and-health-report</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 121788 question first answered 15/01/2018 11:56:59 answering member 4067 label Biography information for Steve Brine
	tabling member	1538 label Biography information for Rosie Cooper

820956

	registered interest
	date	11/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lumacaftor/ivacaftor: France
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health of Social Care, whether he has had recent discussions with his French counterpart on the cost-effectiveness of Orkambi in treating cystic fibrosis.
	tabling member constituency	Glasgow East
	tabling member printed	David Linden
	uin	122374
	answer	answer is ministerial correction date of answer 19/01/2018 answer text <p>We have had no such discussions. The National Institute for Health and Care Excellence (NICE) assessed the cost benefit of Orkambi and was unable to recommend it. Vertex has been encouraged to engage in negotiations with NHS England and if it comes forward with a new proposal, NICE will be able to reconsider.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 122362 122370 122372 question first answered 19/01/2018 11:36:20 answering member 4067 label Biography information for Steve Brine
	tabling member	4640 label Biography information for David Linden

823523

	registered interest
	date	16/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lumacaftor/ivacaftor
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the extension of Orkambi's licence to treat patients aged six and over, what support his Department is giving to further negotiations among NICE, NHS England and the drug manufacturer, Vertex, on access to that medicine for people with cystic fibrosis.
	tabling member constituency	Reigate
	tabling member printed	Crispin Blunt
	uin	122992
	answer	answer is ministerial correction date of answer 24/01/2018 answer text <p>The Department wants patients with cystic fibrosis to benefit from clinically and cost effective treatments, and we welcome the on-going dialogue between Vertex and NHS England to pursue a deal that would make Orkambi available to National Health Service patients.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/01/2018 12:13:27 answering member 4067 label Biography information for Steve Brine
	tabling member	104 label Biography information for Crispin Blunt

825682

	registered interest
	date	19/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coperforma
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Answer of 8 November 2016 to Question 51429, if he will assess the accuracy of the advice he received from NHS England that NHS trusts that have incurred costs invoiced Coperforma directly; and if he will make a statement.
	tabling member constituency	Brighton, Pavilion
	tabling member printed	Caroline Lucas
	uin	123750
	answer	answer is ministerial correction date of answer 29/01/2018 answer text <p>The provision of patient transport services is a matter for local National Health Service commissioners. We are advised by NHS England that the response to Question 51429 was accurate. Until 5 December 2016, Coperforma advised NHS trusts that such invoices should be sent directly to it for processing.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 29/01/2018 16:51:29 answering member 4067 label Biography information for Steve Brine
	tabling member	3930 label Biography information for Caroline Lucas

830015

	registered interest
	date	24/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: Greater London
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Answer of 8 July 2015 to Question 4874, on general practitioners: Greater London, how many (a) general medical services, (b) personal medical services and (c) alternative provider medical services contracts were issued for GP surgeries in (i) Hampstead and Kilburn constituency and (ii) in London in (A) 2016 and (B) 2017.
	tabling member constituency	Hampstead and Kilburn
	tabling member printed	Tulip Siddiq
	uin	124734
	answer	answer is ministerial correction date of answer 01/02/2018 answer text <p>There have been no Alternative Provider Medical Services (APMS), General Medical Services (GMS) or Personal Medical Services (PMS) contracts procured in the Hampstead and Kilburn constituency since 2013.</p><p> </p><p>NHS England has confirmed that across London, 10 APMS contracts were issued in 2016; and in 2017, 14 have been issued with one further contract to go live on 1 March 2018. No GMS or PMS contracts have been issued in London in 2016 or in 2017.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 01/02/2018 11:43:15 answering member 4067 label Biography information for Steve Brine
	tabling member	4518 label Biography information for Tulip Siddiq

820006

	registered interest
	date	10/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radiology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to his announcement of 5 December 2017, that the NHS will employ 300 additional radiologists in connection with the Cancer Workforce Plan, whether any of those positions will be for interventional neuroradiologists trained to perform procedures including mechanical thrombectomy.
	tabling member constituency	West Ham
	tabling member printed	Lyn Brown
	uin	122078
	answer	answer is ministerial correction date of answer 18/01/2018 answer text <p>Health Education England (HEE) published the Cancer Workforce Plan in December 2017 and set out that HEE will invest in 300 reporting radiographers and 668 more clinical radiologists by 2021. At this stage and until training has been commenced it is not known how many of the radiology positions will be taken up by the subspecialty of interventional neuroradiology.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/01/2018 14:14:03 answering member 4067 label Biography information for Steve Brine
	tabling member	1583 label Biography information for Ms Lyn Brown